** = Publikationen gelistet in SCI/SSCI/Pubmed
** Dagnino, F; Pohl, KK; Qian, Z; Zurl, H; Stelzl, D; Korn, SM; Lughezzani, G; Buffi, NM; Kibel, AS; Trinh, QD; Cole, AP
Association of Cannabis Use With Guideline-Recommended Cancer Screenings: Results From a National Health Behaviors Survey.
JCO Oncol Pract. 2025; OP2401093
Doi: 10.1200/OP-24-01093
PubMed
FullText
FullText_MUG
** Korn, SM; Qian, Z; Zurl, H; Hansen, N; Pohl, KK; Stelzl, D; Dagnino, F; Lipsitz, S; Zhang, J; Kibel, AS; Moore, CM; Kilbridge, KL; Shariat, SF; Loeb, S; Vargas, HA; Trinh, QD; Cole, AP
Geographic variability in contemporary utilization of PET imaging for prostate cancer: a medicare claims cohort study.
Cancer Imaging. 2025; 25(1):86
Doi: 10.1186/s40644-025-00898-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Korn, SM; Qian, Z; Zurl, H; Piccolini, A; Pohl, KK; Lipsitz, S; Zhang, J; Kibel, AS; Moore, CM; Rana, HQ; Kilbridge, KL; Shariat, SF; Loeb, S; Trinh, QD; Cole, AP
Disparities in Tissue-based Biomarker Testing Among U.S. Medicare Beneficiaries with Prostate Cancer.
JNCI Cancer Spectr. 2025;
Doi: 10.1093/jncics/pkaf051
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Piccolini, A; Qian, Z; Korn, SM; Dagnino, F; Pohl, K; Zurl, H; Lei, Y; Osman, NY; Lughezzani, G; Buffi, NM; Trinh, QD; Cole, AP
Exploring the Impact of Mental Health on PSA Screening: Insights from a Population-Based Survey.
Urology. 2025;
Doi: 10.1016/j.urology.2025.06.016
PubMed
FullText
FullText_MUG
** Pohl, M; Elshikh, A; Mercaldo, S; Kamran, SC; Cochran, RL; Stranger, N; Nakrour, N; Pohl, K; Fuchsjäger, M; Harisinghani, M
Factors associated with mesorectal lymph node metastasis in prostate cancer patients.
Abdom Radiol (NY). 2025;
Doi: 10.1007/s00261-025-05086-5
Web of Science
PubMed
FullText
FullText_MUG
** Zurl, H; Korn, SM; Pohl, KK; Qian, Z; Piccolini, A; Iyer, HS; Leapman, MS; Ahyai, S; Shariat, SF; Trinh, QD; Thiel, CL; Loeb, S; Cole, AP
Estimating the Carbon Emissions of a Single Prostate-specific Antigen Test: Results from a Cradle-to-grave Life Cycle Assessment.
Eur Urol Focus. 2025;
Doi: 10.1016/j.euf.2025.07.006
PubMed
FullText
FullText_MUG
** Zurl, H; Pohl, KK; Korn, SM; Piccolini, A; Qian, Z; Xiao, B; Zhang, J; Moore, CM; Rebbeck, TR; Kilbridge, KL; Leitsmann, M; Ahyai, S; Kibel, AS; Trinh, QD; Cole, AP
Racial Disparities in the Use of MRI and PET Scan Among Medicare Beneficiaries With Prostate Cancer.
Prostate. 2025;
Doi: 10.1002/pros.70022
PubMed
FullText
FullText_MUG
** Pohl, M; Nakrour, N; Aswani, Y; Ghosh, S; Pohl, K; Elshikh, A; Yatin, M; Cochran, RL; Fuchsjaeger, M; Harisinghani, M
SpaceOAR hydrogel complications in prostate cancer radiotherapy: a pictorial review.
Abdom Radiol (NY). 2025;
Doi: 10.1007/s00261-025-04922-y
Web of Science
PubMed
FullText
FullText_MUG
** Scheipner, L; Jankovic, D; Jasarevic, S; Seidl, M; Altziebler, JV; Pemberger, K; Pohl, KC; Primus, G; Tian, Z; Leitsmann, M; Ahyai, S
Patient reported outcomes of intermittent self-dilatation after direct vision internal urethrotomy.
Neurourol Urodyn. 2024; 43(3):664-671
Doi: 10.1002/nau.25390
Web of Science
PubMed
FullText
FullText_MUG
** Pohl, M; Pohl, K; Fuchsjäger, MH; Ahyai, S; Talakic, E
MR Imaging and Surgical Intervention of Penile Paraffinoma.
Rofo. 2024;
Doi: 10.1055/a-2441-5251
Web of Science
PubMed
FullText
FullText_MUG
** Scheipner, L; Zurl, H; Altziebler, JV; Pichler, GP; Schöpfer-Schwab, S; Jasarevic, S; Gaisl, M; Pohl, KC; Pemberger, K; Andlar, S; Hutterer, GC; Bele, U; Leitsmann, C; Leitsmann, M; Augustin, H; Zigeuner, R; Ahyai, S; Mischinger, J
Charlson-Deyo Comorbidity Index as a novel predictor for recurrence in nonmuscle invasive bladder cancer
EUR UROL. 2024; 85: S2123-S2124.
[Oral Communication]
Web of Science